by McKesson Ventures | Dec 14, 2023 | Press Releases
On Thursday, December 14th, pharmaceutical marketing and trade magazine PM360 announced its list of innovators in the pharmaceutical, biotechnology, medical device, and biotechnology industries. These innovators were named for their achievements across a variety of...
by McKesson Ventures | Dec 8, 2023 | Press Releases
Aster Insights has announced three upcoming presentations at the 2023 American Society of Hematology (ASH) Annual Meeting, which will be held from December 9-12 in San Diego, CA. Three ORIEN scientists from Moffitt Cancer Center will present key findings on multiple...
by McKesson Ventures | Dec 7, 2023 | Press Releases
On Thursday, December 7, 2023, oncology and cancer-health screening company Cancer IQ announced a partnership with the Boston University School of Public Health to study racial and ethnic disparities in genetic counseling and testing for at-risk cancer patients. This...
by McKesson Ventures | Dec 4, 2023 | Press Releases
Telemedicine company Hims & Hers announced the launch of its new weight loss service, “Weight Loss by Hims & Hers,” in a press release on Monday, December 4, 2023. The new service aims to establish itself as a holistic alternative to traditional weight loss...
by McKesson Ventures | Nov 30, 2023 | Press Releases
On Thursday, November 30, 2023, Aledade Inc. announced that it has partnered with Anthem Blue Cross and Blue Shield to increase quality and ease of access for patient care to people throughout the Commonwealth of Virginia. The initiative will provide improved and more...
by McKesson Ventures | Nov 26, 2023 | Press Releases
Densitas Inc, an artificial intelligence and technology company, announced on Sunday that it has partnered with the cancer prevention service CancerIQ to include Cancer IQ’s Tyrer-Cuzick Version 8 risk calculator in its breast cancer screening offerings. This 8th...
